Sort
48,018 grants matching “immunotherapy”
Clinical Neuroimmunology of Vaccines in Brain Tumors
$400,733John H Sampson · Duke University · R01 · FY2022 · NS
Mapping Brain Lipid Architecture in Aging, LBD and T Cell Therapy using novel Imaging Mass Spectrometry
$400,707Vinata Vedam-Mai · University Of Florida · R21 · FY2024 · AG
Proinflammatory T Regulatory Cells in Colon Cancer
$400,690Khashayarsha Khazaie · Northwestern University At Chicago · R01 · FY2012 · CA
Cancer Center Research Training Program
$400,682Stephen Patrick Hunger · University Of Pennsylvania · T32 · FY2019 · CA
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
$400,654Thea Friedman · Hackensack University Medical Center · R01 · FY2010 · CA
Sublingual Immunotherapy for Peanut Allergy
$400,575Arvil Wesley Burks · Duke University · R01 · FY2008 · AT
Targeting eIF4A1 in drug-resistant breast cancer stem-like cells
$400,551Dayanidhi Raman · University Of Toledo Health Sci Campus · R01 · FY2023 · CA
The immunoPeptidoGenomic (iPepGen) informatics resource forimmuno-oncology research
$400,530Timothy J. Griffin · University Of Minnesota · U01 · FY2024 · CA
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
$400,514Jonathan P Schneck · Johns Hopkins University · R33 · FY2020 · CA
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
$400,511Jonathan P Schneck · Johns Hopkins University · R33 · FY2021 · CA
Biomaterials that Promote Infection Immunity
$400,471James D. Bryers · University Of Washington · R56 · FY2015 · AI
Cell intrinsic and extrinsic effects of zinc metabolism in therapy resistant melanoma
$400,461Katherine Marie Aird · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Accelerated CD8 T cell memory after DC vaccination
$400,429John T. Harty · University Of Iowa · R01 · FY2009 · AI
Accelerated CD8 T cell memory after DC vaccination
$400,429John T. Harty · University Of Iowa · R01 · FY2008 · AI
The role of TIM-3 in regulating T cell function during tuberculosis
$400,417Samuel M Behar · Brigham And Women'S Hospital · P01 · FY2017 · AI
Resource for Nonhuman Primate Immune Reagents
$400,383Francois J Villinger · University Of Louisiana At Lafayette · R24 · FY2018 · OD
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$400,345Michael Lim · Stanford University · R01 · FY2023 · NS
Ricin-Mechanism, Transition State and Inhibitor Design
$400,341Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2007 · CA
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival
$400,319Richard Samuel Hotchkiss · Washington University · R35 · FY2018 · GM
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
$400,313Sandra Orsulic · Cedars-Sinai Medical Center · R01 · FY2016 · CA
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
$400,313Sandra Orsulic · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies
$400,313Sandra Orsulic · Cedars-Sinai Medical Center · R01 · FY2017 · CA
qHTS of Patient Derived HCC Models to Identify Novel Probes/Therapeutic Agents
$400,283Paul A. Johnston · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Targeting the Immunosuppressive Tumor Microenvironment for Colorectal Cancer Treatment
$400,276Qingding Wang · University Of Kentucky · R01 · FY2025 · CA
Targeting the Immunosuppressive Tumor Microenvironment for Colorectal Cancer Treatment
$400,276Qingding Wang · University Of Kentucky · R01 · FY2023 · CA